Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Karlsson

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Nature Communications|July 6, 2021
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in gliomaLuuk van Hooren, Alessandra Vaccaro, Mohanraj Ramachandran, et al.
Cancer Research Communications|March 16, 2023
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates RadiotherapyKatrine Ingelshed, Diana Spiegelberg, Pavitra Kannan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2026
Lymphocyte Antigen 6G Mediates Vagotomy-Associated Reduction in Body WeightTing Liu, April S Caravaca, Min Cai, et al.
Cancer Cell|March 7, 2025
Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33Sara Lamorte, Rene Quevedo, Robbie Jin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2018
Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates AtherosclerosisMonica Centa, Kajsa E Prokopec, Manasa G Garimella, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cellsSilke Eisinger, Dhifaf Sarhan, Vanessa F Boura, et al.
Frontiers in Immunology|January 22, 2019
Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid ArthritisKaty A Lloyd, Gustaf Wigerblad, Peter Sahlström, et al.
Nature Communications|May 27, 2018
Testosterone is an endogenous regulator of BAFF and splenic B cell numberAnna S Wilhelmson, Marta Lantero Rodriguez, Alexandra Stubelius, et al.
Nature Communications|July 19, 2016
Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cellsMarisa A P Baptista, Marton Keszei, Mariana Oliveira, et al.
RSC Chemical Biology|April 2, 2025
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in <i>BTK</i>/<i>Tec</i> double deficient X-linked agammaglobulinemia modelBurcu Bestas, H Yesid Estupiñán, Qing Wang, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Nature Communications|July 6, 2021
Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in gliomaLuuk van Hooren, Alessandra Vaccaro, Mohanraj Ramachandran, et al.
Cancer Research Communications|March 16, 2023
The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth <i>In Vivo</i> and Potentiates RadiotherapyKatrine Ingelshed, Diana Spiegelberg, Pavitra Kannan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 4, 2026
Lymphocyte Antigen 6G Mediates Vagotomy-Associated Reduction in Body WeightTing Liu, April S Caravaca, Min Cai, et al.
Cancer Cell|March 7, 2025
Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33Sara Lamorte, Rene Quevedo, Robbie Jin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2018
Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates AtherosclerosisMonica Centa, Kajsa E Prokopec, Manasa G Garimella, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2020
Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cellsSilke Eisinger, Dhifaf Sarhan, Vanessa F Boura, et al.
Frontiers in Immunology|January 22, 2019
Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid ArthritisKaty A Lloyd, Gustaf Wigerblad, Peter Sahlström, et al.
Nature Communications|May 27, 2018
Testosterone is an endogenous regulator of BAFF and splenic B cell numberAnna S Wilhelmson, Marta Lantero Rodriguez, Alexandra Stubelius, et al.
Nature Communications|July 19, 2016
Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cellsMarisa A P Baptista, Marton Keszei, Mariana Oliveira, et al.
RSC Chemical Biology|April 2, 2025
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in <i>BTK</i>/<i>Tec</i> double deficient X-linked agammaglobulinemia modelBurcu Bestas, H Yesid Estupiñán, Qing Wang, et al.
Pageof 20